264,259 Shares in Cognex Corporation $CGNX Purchased by Bank of Nova Scotia

Bank of Nova Scotia bought a new stake in Cognex Corporation (NASDAQ:CGNX) during the 2nd quarter, HoldingsChannel.com reports. The firm bought 264,259 shares of the scientific and technical instruments company’s stock, valued at approximately $8,382,000.

Other large investors also recently bought and sold shares of the company. Nordea Investment Management AB raised its holdings in Cognex by 148.5% in the 2nd quarter. Nordea Investment Management AB now owns 7,075,772 shares of the scientific and technical instruments company’s stock valued at $223,594,000 after acquiring an additional 4,228,729 shares during the last quarter. T. Rowe Price Investment Management Inc. lifted its stake in shares of Cognex by 32.0% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 6,082,319 shares of the scientific and technical instruments company’s stock valued at $181,436,000 after purchasing an additional 1,474,832 shares during the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of Cognex by 34.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,539,557 shares of the scientific and technical instruments company’s stock valued at $75,756,000 after acquiring an additional 647,955 shares during the period. Federated Hermes Inc. lifted its stake in Cognex by 131.0% during the 2nd quarter. Federated Hermes Inc. now owns 1,619,607 shares of the scientific and technical instruments company’s stock worth $51,374,000 after acquiring an additional 918,413 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Cognex by 5.6% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,507,022 shares of the scientific and technical instruments company’s stock valued at $44,954,000 after acquiring an additional 79,266 shares during the period. Hedge funds and other institutional investors own 88.12% of the company’s stock.

Cognex Stock Performance

CGNX opened at $37.91 on Thursday. Cognex Corporation has a one year low of $22.67 and a one year high of $49.76. The company has a market cap of $6.35 billion, a P/E ratio of 59.24 and a beta of 1.53. The business’s 50-day simple moving average is $41.50 and its 200-day simple moving average is $39.01.

Cognex (NASDAQ:CGNX) last announced its quarterly earnings results on Wednesday, October 29th. The scientific and technical instruments company reported $0.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.06. The firm had revenue of $264.00 million during the quarter, compared to the consensus estimate of $261.86 million. Cognex had a return on equity of 8.26% and a net margin of 11.33%.The firm’s quarterly revenue was up 18.0% compared to the same quarter last year. During the same period in the prior year, the company posted $0.20 earnings per share. Cognex has set its Q4 2025 guidance at 0.190-0.24 EPS. As a group, analysts predict that Cognex Corporation will post 0.61 earnings per share for the current fiscal year.

Cognex Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 28th. Investors of record on Thursday, November 13th were given a $0.085 dividend. This is a positive change from Cognex’s previous quarterly dividend of $0.08. The ex-dividend date was Thursday, November 13th. This represents a $0.34 annualized dividend and a yield of 0.9%. Cognex’s payout ratio is currently 53.13%.

Insiders Place Their Bets

In other Cognex news, Director Robert Willett sold 6,704 shares of the firm’s stock in a transaction on Tuesday, October 21st. The shares were sold at an average price of $49.51, for a total transaction of $331,915.04. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 1.60% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the stock. UBS Group reissued a “buy” rating and set a $58.00 price target on shares of Cognex in a research report on Friday, October 31st. DA Davidson set a $38.00 target price on shares of Cognex and gave the stock a “neutral” rating in a research note on Monday, November 3rd. The Goldman Sachs Group raised their price target on shares of Cognex from $36.00 to $40.00 and gave the company a “sell” rating in a research report on Tuesday, September 16th. Truist Financial set a $45.00 price target on shares of Cognex and gave the stock a “hold” rating in a research note on Wednesday, October 8th. Finally, Barclays reiterated an “overweight” rating and issued a $56.00 price objective (up from $55.00) on shares of Cognex in a research note on Friday, October 31st. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, Cognex currently has a consensus rating of “Hold” and a consensus target price of $45.53.

About Cognex

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.